Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease.
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease.
-
ナレーター：
-
著者：
Got dry mouth, dry eyes, joint pains, chronic fatigue? Get checked for often-undiagnosed Sjögren’s Disease. Watch this video podcast with rheumatologist & Sjogren's expert, Sara McCoy, M.D. discussing Novartis #ianalumab FDA Breakthrough Therapy Designation. More information is available at: https://www.novartis.com/news/media-releases/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-sjogrens-diseaseandhttps://sjogrens.org/andhttps://www.uwhealth.org/providers/sara-s-mccoy-mdandhttps://www.novartis.com/us-en/patients-and-caregiversWatch all 145 episodes of the #DoctorPodcasts || Cykiert Files video podcast interview show with physicians, scientists, healthcare specialists, entrepreneurs and other experts http://Doctorpodcasts.com/index-of-doctoof-doctoof-doctoof-doctorpodcasts-episodes. Please SUBSCRIBE & FOLLOW @DoctorPodcasts . Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments, suggestions, reviews and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.#Sjogrens
#SjogrensSyndrome
#SjogrensDisease
#Autoimmune
#AutoimmuneDisease
#Rheumatology
#DryEyesDryMouth
#ChronicFatigue
#InvisibleIllness
#ChronicIllness
#RareDiseaseAwareness
#BreakthroughTherapy
#PatientEducation
#MedicalPodcast
#HealthPodcast
#WomenAndAutoimmunity
#LivingWithSjogrens
#RheumLife